Cargando…
Combined treatment for a large primary cardiac sarcoma: a case report
BACKGROUND: Undifferentiated pleomorphic sarcoma (UPS) as a primary cardiac tumor is rare, with extremely poor prognosis owing to high recurrence and invasion. We encountered a patient who presented with a primary cardiac tumor incarcerating the mitral valve and who was in a shock state. CASE PRESEN...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579800/ https://www.ncbi.nlm.nih.gov/pubmed/31209653 http://dx.doi.org/10.1186/s40792-019-0658-x |
_version_ | 1783427905280278528 |
---|---|
author | Akishima, Shinji Imai, Akito Enomoto, Yoshiharu Shigeta, Osamu |
author_facet | Akishima, Shinji Imai, Akito Enomoto, Yoshiharu Shigeta, Osamu |
author_sort | Akishima, Shinji |
collection | PubMed |
description | BACKGROUND: Undifferentiated pleomorphic sarcoma (UPS) as a primary cardiac tumor is rare, with extremely poor prognosis owing to high recurrence and invasion. We encountered a patient who presented with a primary cardiac tumor incarcerating the mitral valve and who was in a shock state. CASE PRESENTATION: A 41-year-old man was transported emergently to our hospital owing to acute respiratory distress and hemoptysis. He was diagnosed with acute left heart failure caused by a large mass in the left atrium (LA) that obstructed cardiac blood flow, as revealed by imaging study findings, and he underwent an emergency open-heart surgery for tumor resection. He was pathologically diagnosed with UPS invading the muscle layer of the LA. However, after receiving combined therapy for local recurrence and distant metastasis, including proton beam radiotherapy and chemotherapy with molecularly targeted drugs, he could return to work for 2 more years after surgery. CONCLUSION: In this study, we reported the case of a patient who was in a state of shock state owing to the presence of UPS in the LA. The patient underwent an emergency surgery and received combined therapy. He survived for 2 more years after an initial diagnosis, without active local recurrence and distant metastasis. |
format | Online Article Text |
id | pubmed-6579800 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-65798002019-07-05 Combined treatment for a large primary cardiac sarcoma: a case report Akishima, Shinji Imai, Akito Enomoto, Yoshiharu Shigeta, Osamu Surg Case Rep Case Report BACKGROUND: Undifferentiated pleomorphic sarcoma (UPS) as a primary cardiac tumor is rare, with extremely poor prognosis owing to high recurrence and invasion. We encountered a patient who presented with a primary cardiac tumor incarcerating the mitral valve and who was in a shock state. CASE PRESENTATION: A 41-year-old man was transported emergently to our hospital owing to acute respiratory distress and hemoptysis. He was diagnosed with acute left heart failure caused by a large mass in the left atrium (LA) that obstructed cardiac blood flow, as revealed by imaging study findings, and he underwent an emergency open-heart surgery for tumor resection. He was pathologically diagnosed with UPS invading the muscle layer of the LA. However, after receiving combined therapy for local recurrence and distant metastasis, including proton beam radiotherapy and chemotherapy with molecularly targeted drugs, he could return to work for 2 more years after surgery. CONCLUSION: In this study, we reported the case of a patient who was in a state of shock state owing to the presence of UPS in the LA. The patient underwent an emergency surgery and received combined therapy. He survived for 2 more years after an initial diagnosis, without active local recurrence and distant metastasis. Springer Berlin Heidelberg 2019-06-17 /pmc/articles/PMC6579800/ /pubmed/31209653 http://dx.doi.org/10.1186/s40792-019-0658-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Case Report Akishima, Shinji Imai, Akito Enomoto, Yoshiharu Shigeta, Osamu Combined treatment for a large primary cardiac sarcoma: a case report |
title | Combined treatment for a large primary cardiac sarcoma: a case report |
title_full | Combined treatment for a large primary cardiac sarcoma: a case report |
title_fullStr | Combined treatment for a large primary cardiac sarcoma: a case report |
title_full_unstemmed | Combined treatment for a large primary cardiac sarcoma: a case report |
title_short | Combined treatment for a large primary cardiac sarcoma: a case report |
title_sort | combined treatment for a large primary cardiac sarcoma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579800/ https://www.ncbi.nlm.nih.gov/pubmed/31209653 http://dx.doi.org/10.1186/s40792-019-0658-x |
work_keys_str_mv | AT akishimashinji combinedtreatmentforalargeprimarycardiacsarcomaacasereport AT imaiakito combinedtreatmentforalargeprimarycardiacsarcomaacasereport AT enomotoyoshiharu combinedtreatmentforalargeprimarycardiacsarcomaacasereport AT shigetaosamu combinedtreatmentforalargeprimarycardiacsarcomaacasereport |